| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,114,515 | 1,731,757 | 1,022,466 | 1,200,506 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 1,731,757 | 1,022,466 | 1,200,506 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 624,642 | 939,023 | 602,493 | 1,041,584 | | Non Recurring |
-
| (203,317) | 203,317 |
-
| | Others | (175,852) | 460,138 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 638,571 | 535,913 | 216,656 | 158,922 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (961) | (4,550) |
-
| 14,041 | | Earnings Before Interest And Taxes | 664,764 | 531,363 | 216,656 | 172,963 | | Interest Expense | 6,161 | 6,336 | 9,146 | 12,541 | | Income Before Tax | 658,603 | 525,027 | 207,510 | 160,422 | | Income Tax Expense | 93,433 | 56,953 | 59,812 | 59,910 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 565,153 | 474,268 | 141,521 | 95,290 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 566,705 | 474,268 | 141,521 | 95,290 | | Preferred Stock And Other Adjustments | (8,631) | (8,632) | (8,631) | (8,631) | | | Net Income Applicable To Common Shares | $558,074 | $465,636 | $132,890 | $86,659 |
|
1.52% Nasdaq 
Income Statement
